Filing metadata

Accession number
0001415889-24-017220
Form type
Form 4
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Jun 17, 2024
Reporting period
Jun 14, 2024
Description
Insider transaction

Explore SEC Filings Hub